FindTrial
Sign In

Changes in blood investigation IN DENGUE cases admitted at sir T hospital,gujarat.

HEMATOLOGICAL AND COAGULATION PROFILE IN DENGUE cases admitted at tertiary care center, Bhavnagar.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057395
Enrollment
100
Registered
2023-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B25-B34- Other viral diseases

Interventions

None listed

Sponsors

GOVERNMENT MEDICAL COLLEGE, BHAVNAGAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hospitalised cases of dengue NS1 antigen, Ig M, positive cases

Exclusion criteria

Exclusion criteria: Other conditions associated with dengue which include similar hematological changes like ITP, Aplastic anemia, infections leading to thrombocytopenia, bone marrow failure, cancer, exposure to radiotherapy etc. Drugs affecting the hematological profile and coagulation profile like warfarin, heparin, antiplatelate drugs ,anticancer drug etc..

Design outcomes

Primary

MeasureTime frame
to assess the hematological dynamics of patients with dengue fever in order to increase the sensitivity of the screening by healthcare professionals in the most serious cases.Timepoint: 15 months—

Secondary

MeasureTime frame
to identify laboratory markers that may indicate the severity and outcome of disease.Timepoint: 15 months—

Countries

India

Contacts

Public ContactDr Alpeshpuri Goswami

GOVERNMENT MEDICAL COLLEGE, BHAVNAGAR

dralpeshgosai79@yahoo.co.in9428125028

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026